BRIEF-Immunomedics reports positive data on urothelial cancer drug
April 19, 2016 at 07:18 AM EDT
* Immunomedics reports sacituzumab govitecan shows significant clinical activity in metastatic urothelial cancer
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.